Pharmafile Logo
Pharmafocus logo
Advanced Search

NICE to review local formularies

February 6, 2012

News

PM Society unveils new look

February 3, 2012

News

Succinct to join OPEN Health

February 3, 2012

News

GP group mounts full opposition to health reforms

February 3, 2012

News

Roche rounds off year with solid performance

February 3, 2012
Sales and Marketing Roche

A strong performance in its diagnostics division was among the factors enabling Roche to deliver a solid set of results …

News

Andrew Morgan joins Republic M!

February 2, 2012
Business Services, Medical Communications, Sales and Marketing Andrew Morgan, Republic M!

Republic M! has strengthened its team with the appointment of Andrew Morgan as head of operations. Andrew has leadership expertise …

Appointment
Merck image

Merck posts strong results for 2011

February 2, 2012
Sales and Marketing Frazier, Merck, Singulair, Victrelis

Foreign exchange rates and strong sales from established products helped Merck to achieve single-digit growth for 2011.  The US firm …

News

Working Life: Carlos Gallardo, general manager, Almirall

February 2, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Almirall, Carlos Gallardo

BiographyCarlos Gallardo is general manager of the Almirall UK and Ireland affiliate from its creation in 2008. He has an …

Feature
AstraZeneca picture

AstraZeneca to cut 7,300 jobs as growth stalls

February 2, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing AZ, AstraZeneca, David Brennan, R&D

AstraZeneca will make 7,300 cuts to its sales and R&D staff by 2014, but the company has not yet said …

News
Pfizer picture

Pfizer recalls oral contraceptive for packaging errors

February 2, 2012
Manufacturing and Production Akrimax, Bedford, Cephalon, Lo/Ovral-28, Pfizer, Teva

Pfizer has been forced to recall a large volume of oral contraceptive packs distributed in the US market because a …

News
Zytiga image

Zytiga cost too high, says NICE

February 2, 2012
Sales and Marketing NICE, Zytiga

NICE is not recommending Janssen’s prostate cancer pill Zytiga because of its high cost. Zytiga (abiraterone) is not recommended, in …

News

RSA announces promotions

February 2, 2012
Medical Communications, Sales and Marketing rsa

Life sciences executive search and interim management specialist firm RSA, has announced its latest promotions.John Callagher (pictured) has been promoted …

Appointment

Sigma-Aldrich acquires testing company BioReliance

February 1, 2012
Research and Development Sigma-Aldrich

Sigma-Aldrich has acquired clinical testing company BioReliance for $350 million. Purchased from Avista Capital Partners, BioReliance provides services that include …

News

Pfizer weathers patent expiry storm

February 1, 2012

Pfizer has managed to keep its head above water in its full year results, but faces a tough 2012 without …

News

Kalydeco to be landmark in cystic fibrosis treatment

February 1, 2012
Vertex, cystic fibrosis, telaprevir

Vertex’s first-in-class treatment for cystic fibrosis Kalydeco has been approved by the FDA. The approval is a landmark in the …

News

NHS reforms criticised by healthcare journals

January 31, 2012
Sales and Marketing BMJ, GPs, Lansley, NHS reforms, nursing times

A trio of leading healthcare journals has come out against the government’s NHS reforms. The British Medical Journal is leading …

News

Catalent expands controlled release drug development and supply capabilities at its Schorndorf, Germany Facility

January 31, 2012
Manufacturing and Production

Somerset, NJ –January 25, 2012 — Catalent Pharma Solutions continues to expand its drug development and delivery capabilities to help …

News
Press release

Catalent acquires current minority interest in R.P. Scherer, Eberbach, Germany

January 31, 2012
Manufacturing and Production

SOMERSET, NJ, January 30, 2012 – Catalent Pharma Solutions, a leading global drug delivery technology company, today announced the signing …

News
Press release
Ranbaxy picture

Ranbaxy taken to task by FDA over manufacturing woes

January 31, 2012
Manufacturing and Production FDA, Ranbaxy, manufacturing, woes

Indian pharma company Ranbaxy will be banned from manufacturing drugs at certain plants for the US market until it corrects …

News

GMP issues affect Mircera, Xenical production at Roche plant

January 31, 2012
Manufacturing and Production GMP, Mircera, Roche, Tamiflu, Xenical

Supply of two Roche products has been disrupted after an active pharmaceutical ingredient (API) production facility in the US was …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026